The reasons behind this sex difference arent fully understood, but likely relate to baseline hormonal profiles, the interaction between semaglutide and estrogen-related metabolic pathways, and the higher prevalence of insulin-resistance-driven weight gain in women conditions that GLP-1 mechanisms are particularly well-suited to address.
Plasma levels of pro-inflammatory cytokines, including TNF-, IL-6, and IL-1 were significantly upregulated in temporal lobe epilepsy patients [58]
Patients who view tirzepatide as a tool enabling lifestyle change rather than a standalone solution experience better psychological adjustment and maintenance
1 However, Trulicity isnt licensed for weight loss in the UK
A dual-incretin medication that acts on two pathways, GLP-1 and GIP, in a once-daily tablet instead of a weekly shot